London-based VC Atomico just announced new funds, with a specialised team for each stage of maturity. The new €681 million Atomico Growth VI partners with entrepreneurs from Series B to pre-IPO. It sits alongside a €438 million early stage fund, Atomico Venture VI, which continues its commitment to working with founders earlier in their journey, predominantly at Series A, alongside occasional Seed opportunities.
According to the VC, Atomico was founded with the vision that exceptional companies can come from anywhere. Since inception they’ve partnered with founders from series A, expanding to include growth investments in 2011.
“European technology is coming of age. Meeting this opportunity requires ambition, hustle and commitment from founders, who need investors with the experience and perspective to see beyond market cycles. Data shows Europe is leading the world at the early stage with a wealth of new start-ups. Our new funds bring them essential fire power to level up and achieve global scale – from Europe,” said Niklas Zennström, founder and CEO, Atomico.
The new funds come as the $3 trillion European ecosystem begins to rival its global counterparts. Europe now captures close to 30 per cent of global early stage funding and is creating more new companies than any other region.
Atomico believes that entrepreneurs are the ultimate gamechangers for positive transformation across our society and economy. With this purpose in mind, they continue to be a generalist technology investor, partnering across verticals where they see the most ambitious founders building for positive outcomes. According to the VC, they take a founder-focussed approach to helping European entrepreneurs succeed, with hands-on support from a platform of world class operational leaders.
Combined, they have already made 21 investments from the new funds. Atomico Growth VI has most recently partnered with Cologne’s DeepL, Copenhagen’s Corti and London-born virtual clinic provider Pelago. Atomico Venture VI investments include Stockholm’s Neko Health, London’s Ben and Dexory, Berlin’s Deeploi, Oslo’s Strise and Zurich’s Lakera.
“When we chose to partner with Atomico, our motivation was more than just funding; it was about finding a collaborator who truly understands what it will take to build the world’s most trusted generative AI for healthcare. Atomico has been a partner in every sense, diving straight into the trenches to navigate the complexities of scaling responsibly and effectively,” added Andreas Cleve, co-founder and CEO, Corti
Since Atomico was founded in 2006, they’ve made over 155 investments across 15 European countries. 1 in 6 of Atomico’s portfolio is currently valued in excess of $1 billion.
